Do Non-steroidal Anti-inflammatory Drugs Cause Exacerbations of Inflammatory Bowel Disease?

被引：28
作者：
Feagins, Linda A. [1 ,2 ,3 ]
Cryer, Byron L. [1 ,2 ,3 ]
机构：
[1] VA N Texas Hlth Care Syst, Div Gastroenterol 111B1, Dallas, TX 75216 USA
[2] VA N Texas Hlth Care Syst, Div Hepatol, Dallas, TX 75216 USA
[3] Univ Texas SW Med Ctr Dallas, Dallas, TX 75216 USA
来源：
DIGESTIVE DISEASES AND SCIENCES | 2010年 / 55卷 / 02期
关键词：
Non-steroidal anti-inflammatory drugs; Inflammatory bowel disease; Crohn's disease; Ulcerative colitis; SELECTIVE CYCLOOXYGENASE-2 INHIBITORS; OPEN-LABEL TRIAL; ULCERATIVE-COLITIS; GASTROINTESTINAL-TRACT; RELAPSE; EICOSANOIDS; ROFECOXIB; REMISSION; INGESTION; CELECOXIB;
D O I：
10.1007/s10620-009-1042-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
The safety of non-steroidal anti-inflammatory drugs ( NSAIDs) in patients with inflammatory bowel disease (IBD) remains unclear. This report discusses potential mechanisms whereby NSAIDs might exacerbate IBD and reviews the available clinical data on the role of NSAIDs in causing exacerbations of ulcerative colitis (UC) and Crohn's disease ( CD).
引用
收藏
页码：226 / 232
页数：7
相关论文
共 38 条
[1]   Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial [J].
Biancone, L ;
Tosti, C ;
Geremia, A ;
Fina, D ;
Petruzziello, C ;
Emerenziani, S ;
Pallone, F .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (07) :755-764
[2]  
Bonner GF, 2000, AM J GASTROENTEROL, V95, P1946
[3]   A long-term cohort study of nonsteroidal anti-inflammatory drug use and disease activity in outpatients with inflammatory bowel disease [J].
Bonner, GF ;
Fakhri, A ;
Vennamaneni, SR .
INFLAMMATORY BOWEL DISEASES, 2004, 10 (06) :751-757
[4]   Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial [J].
Bresalier, RS ;
Sandler, RS ;
Quan, H ;
Bolognese, JA ;
Oxenius, B ;
Horgan, K ;
Lines, C ;
Riddell, R ;
Morton, D ;
Lanas, A ;
Konstam, MA ;
Baron, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (11) :1092-1102
[5]   STAT3 and NF-κB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice [J].
Cho, Mi-La ;
Kang, Jung-Won ;
Moon, Young-Mee ;
Nam, Hyo-Jung ;
Jhun, Joo-Yeon ;
Heo, Seong-Beom ;
Jin, Hyun-Tak ;
Min, So-Youn ;
Ju, Ji-Hyeon ;
Park, Kyung-Su ;
Cho, Young-Gyu ;
Yoon, Chong-Hyeon ;
Park, Sung-Hwan ;
Sung, Young-Chul ;
Kim, Ho-Youn .
JOURNAL OF IMMUNOLOGY, 2006, 176 (09) :5652-5661
[6]  
CRYER BL, 2006, PEPTIC ULCER DIS SLE
[7]  
D'Acquisto Fulvio, 2002, Mol Interv, V2, P22, DOI 10.1124/mi.2.1.22
[8]  
Davies NM, 1999, J PHARM PHARM SCI, V2, P5
[9]   Role of Intestinal Mucins in Innate Host Defense Mechanisms against Pathogens [J].
Dharmani, Poonam ;
Srivastava, Vikas ;
Kissoon-Singh, Vanessa ;
Chadee, Kris .
JOURNAL OF INNATE IMMUNITY, 2009, 1 (02) :123-135
[10]   EICOSANOIDS AND THE GASTROINTESTINAL-TRACT [J].
EBERHART, CE ;
DUBOIS, RN .
GASTROENTEROLOGY, 1995, 109 (01) :285-301
1234